+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Sulfated polysaccharides and a synthetic sulfated polymer are potent inhibitors of Chlamydia trachomatis infectivity in vitro but lack protective efficacy in an in vivo murine model of chlamydial genital tract infection



Sulfated polysaccharides and a synthetic sulfated polymer are potent inhibitors of Chlamydia trachomatis infectivity in vitro but lack protective efficacy in an in vivo murine model of chlamydial genital tract infection



Infection and Immunity 66(3): 1258-1260



Heparin, dextran sulfate, pentosan polysulfate, and a sulfated synthetic copolymer of acrylic acid and vinyl alcohol were shown to be potent inhibitors of Chlamydia trachomatis infectivity for cultured human epithelial cells. Despite their potent antichlamydial activity in vitro, neither heparin nor dextran sulfate was effective in inhibiting the infectivity of C. trachomatis in a murine model of chlamydial infection of the female genital tract.

(PDF emailed within 1 workday: $29.90)

Accession: 009488984

Download citation: RISBibTeXText

PMID: 9488423


Related references

Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: Serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection. Vaccine 13(11): 1023-1032, 1995

Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infection and Immunity 63(12): 4704-4714, 1995

Chlamydia trachomatis infection of cells derived from the human cervix is blocked by sulfated polysaccharides. Abstracts of the General Meeting of the American Society for Microbiology 95(0): 197, 1995

Chlamydial genital tract infections. Experimental infection of the primate genital tract with Chlamydia trachomatis. American Journal of Pathology 106(1): 132-135, 1982

Identification of candidate genes using the murine model of female genital tract infection with Chlamydia trachomatis. Drugs of Today 45 Suppl B: 51-59, 2010

Imiquimod does not affect shedding of viable chlamydiae in a murine model of Chlamydia trachomatis genital tract infection. Infectious Diseases in Obstetrics and Gynecology 11(2): 81-87, 2003

Antiparasitic effects of nitric oxide in an in vitro murine model of Chlamydia trachomatis infection and an in vivo murine model of Leishmania major infection. Immunology Series 60: 179-195, 1994

Sulfated polysaccharides block chlamydia infection in vitro, but do not protect mice from vaginal inoculation. Microbial Pathogenesis 24(4): 253-256, 1998

A Synthetic, Small, Sulfated Agent Is a Promising Inhibitor of Chlamydia spp. Infection in vivo. Frontiers in Microbiology 9: 3269-3269, 2019

The significance of serum specific IgA antibody to Chlamydia trachomatis in the diagnosis and treatment of chlamydial infection in female genital tract. Nihon Sanka Fujinka Gakkai Zasshi 41(4): 479-486, 1989

Subclinical chlamydial infection of the female mouse genital tract generates a potent protective immune response: implications for development of live attenuated chlamydial vaccine strains. Infection and Immunity 68(1): 192-196, 1999

Subclinical Chlamydial Infection of the Female Mouse Genital Tract Generates a Potent Protective Immune Response: Implications for Development of Live Attenuated Chlamydial Vaccine Strains. Infection and Immunity 68(1): 192-196, 2000

DNA immunization with pgp3 gene of Chlamydia trachomatis inhibits the spread of chlamydial infection from the lower to the upper genital tract in C3H/HeN mice. Vaccine 21(11-12): 1089-1093, 7 March, 2003

Transient detection of Chlamydial-specific Th1 memory cells in the peripheral circulation of women with history of Chlamydia trachomatis genital tract infection. American Journal of Reproductive Immunology 68(6): 499-506, 2013

Protective immunity following infection in experimental chlamydia trachomatis ct genital tract infection gti. Clinical Research 36(1): 146A, 1988